A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma

Adjuvant treatment modalities, prognostic predictors and outcomes of uterine carcinosarcomas

Gungorduk K.
Ozdemir A.
Ertas I.E.
Gokcu M.
Telli E.
Oge T.
Sahbaz A.

January 2015

Purpose The purpose of this study is to evaluate the clinicopathological characteristics, treatment,...

The Role of Adjuvant Chemotherapy in Surgical Stages I-II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium A Collaborative Study

Vandenput, Ingrid
Trovik, Jone
Vergote, Ignace
Moerman, Philippe
Leunen, Karin
Berteloot, Patrick
Neven, Patrick
Salvesen, Helga
Amant, Frédéric

January 2011

Objective: To assess the impact of adjuvant chemotherapy in early surgically staged type II endometr...

Clinical outcomes of uterine carcinosarcoma results of 94 patients

Gökçe, Zeynep Kestel
Turan, Taner
Karalok, Alper
Tasçı, Tolga
Üreyen, Işın
Özkaya, Enis
Köse, Mehmet Faruk
Tulunay, Gökhan

January 2015

WOS: 000348831000015PubMed ID: 25611900Objective: We aimed to determine the clinicopathologic featur...

A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma

Dickson, Elizabeth L.
Vogel, Rachel Isaksson
Gehrig, Paola A.
Pierce, Stuart
Havrilesky, Laura
Secord, Angeles Alvarez
Dottino, Joseph
Fader, Amanda N.
Ricci, Stephanie
Geller, Melissa A.

January 2015

To evaluate the use of adjuvant therapy after primary surgery for stage I–III uterine carcinosarcoma...

Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma

Kimyon Cömert, Günsu
Türkmen, Osman
Boyraz, Gökhan
Yalçın, İbrahim
Altın, Duygu
Karalök, Alper
Şahin, Hanifi
Taşkın, Salih
Başaran, Derman
Fırat Cuylan, Zeliha
Koyuncu, Kazibe
Salman, Mehmet Coşkun
Özgül, Nejat
Meydanlı, Mehmet Mutlu
Turan, Taner
Ortaç, Fırat
Yüce, Kunter

January 2019

Background: Uterine carcinosarcoma is rare neoplasm that mostly presents as metastatic disease. Stag...

Adjuvant therapy and prognosis in uterine carcinosarcoma

Chi-Yuan Chiang
Huei-Jean Huang
Wei-Yang Chang
Lan-Yan Yang
Ren-Chin Wu
Chun-Chieh Wang
Hsiu-Jung Tung
Angel Chao
Chyong-Huey Lai

November 2021

Purpose: To investigate the prognostic factors and impact of adjuvant treatment on uterine carcinosa...

Role of surgical staging and adjuvant chemotherapy in the treatment of uterine carcinosarcoma

Cabrera, O.
Cho, C.
Dalmar, Ahmed
Mahdavi, Ali

April 2015

Objectives: To determine the clinical behavior and role of chemotherapy and surgical staging in the ...

Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08)

김용배
김준원
차지혜

October 2017

OBJECTIVE: To investigate the role of radiotherapy (RT) in patients who underwent hysterectomy for u...

The role of multimodal adjuvant therapy for FIGO I-II carcinosarcoma of the uterus:a systematic review

van der Horst, R L
van der Hel, O
Lutgens, L
van der Aa, M
Slangen, B
Kruitwagen, R
Lalisang, R I

July 2022

The uterine carcinosarcoma (UCS) is a rare entity with poor prognosis. Treatment of FIGO I-II UCS us...

Adjuvant Vaginal Cuff Brachytherapy and Patterns of Failure for Early Stage Uterine Carcinosarcoma

Zhu, Simeng
Khalil, Remonda M
Burmeister, Charlotte
Elshaikh, Mohamed A

January 2019

Purpose: Uterine carcinosarcoma (UCS)is a rare histologic type, for which the optimal adjuvant manag...

The Impact of Different Adjuvant Management Strategies on Survival Endpoints in Women with Early Stage Uterine Serous Carcinoma

Cook, Andrew E
Khalil, Remonda M
Burmeister, Charlotte
Dimitrova, Irina
Elshaikh, Mohamed A

November 2020

Purpose/Objective(s): To determine the impact of adjuvant chemotherapy, radiation treatment, combine...

Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study

Versluis, Marco A C
Pielsticker, Cindy
van der Aa, Maaike A
de Bruyn, Marco
Hollema, Harry
Nijman, Hans W

January 2018

OBJECTIVE: Uterine carcinosarcoma is a rare, aggressive subtype of endometrial cancer. Treatment con...

Is the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from That of Grade 3 Endometrioid Adenocarcinoma?

Gungorduk, Kemal
Plett, Helmut
Gulseren, Varol
Meydanli, Mutlu
Boyraz, Gokhan
Ozdemir, IsaAykut
Oge, Tufan

January 2021

Aim: The clinicopathologic characteristics, recurrence patterns, and survival of patients with grade...

Carcinosarcomas of the uterus: prognostic factors and impact of adjuvant treatment

Beckmann, K.
Selva-Nayagam, S.
Olver, I.
Miller, C.
Buckley, E.S.
Powell, K.
Buranyi-Trevarton, D.
Gowda, R.
Roder, D.
Oehler, M.K.

January 2021

Background: Uncertainties remain about the most effective treatment for uterine carcinosarcoma (UCS)...

Supplementary Material for: Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study

Nijman, Hans W.
De Bruyn, Marco
Versluis, Marco
Van Der Aa, Maaike A.
Hollema, Harry
Pielsticker, Cindy
Translational Immunology Groningen (TRIGR)
Targeted Gynaecologic Oncology (TARGON)
University Medical Center Groningen

July 2018

Objective: Uterine carcinosarcoma is a rare, aggressive subtype of endometrial cancer. Treatment con...

Adjuvant treatment modalities, prognostic predictors and outcomes of uterine carcinosarcomas

Gungorduk K.
Ozdemir A.
Ertas I.E.
Gokcu M.
Telli E.
Oge T.
Sahbaz A.

January 2015

Purpose The purpose of this study is to evaluate the clinicopathological characteristics, treatment,...

The Role of Adjuvant Chemotherapy in Surgical Stages I-II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium A Collaborative Study

Vandenput, Ingrid
Trovik, Jone
Vergote, Ignace
Moerman, Philippe
Leunen, Karin
Berteloot, Patrick
Neven, Patrick
Salvesen, Helga
Amant, Frédéric

January 2011

Objective: To assess the impact of adjuvant chemotherapy in early surgically staged type II endometr...

Clinical outcomes of uterine carcinosarcoma results of 94 patients

Gökçe, Zeynep Kestel
Turan, Taner
Karalok, Alper
Tasçı, Tolga
Üreyen, Işın
Özkaya, Enis
Köse, Mehmet Faruk
Tulunay, Gökhan

January 2015

WOS: 000348831000015PubMed ID: 25611900Objective: We aimed to determine the clinicopathologic featur...

A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma

Dickson, Elizabeth L.
Vogel, Rachel Isaksson
Gehrig, Paola A.
Pierce, Stuart
Havrilesky, Laura
Secord, Angeles Alvarez
Dottino, Joseph
Fader, Amanda N.
Ricci, Stephanie
Geller, Melissa A.

January 2015

To evaluate the use of adjuvant therapy after primary surgery for stage I–III uterine carcinosarcoma...

Effect of Adjuvant Therapy on Oncologic Outcomes of Surgically Confirmed Stage I Uterine Carcinosarcoma

Kimyon Cömert, Günsu
Türkmen, Osman
Boyraz, Gökhan
Yalçın, İbrahim
Altın, Duygu
Karalök, Alper
Şahin, Hanifi
Taşkın, Salih
Başaran, Derman
Fırat Cuylan, Zeliha
Koyuncu, Kazibe
Salman, Mehmet Coşkun
Özgül, Nejat
Meydanlı, Mehmet Mutlu
Turan, Taner
Ortaç, Fırat
Yüce, Kunter

January 2019

Background: Uterine carcinosarcoma is rare neoplasm that mostly presents as metastatic disease. Stag...

Adjuvant therapy and prognosis in uterine carcinosarcoma

Chi-Yuan Chiang
Huei-Jean Huang
Wei-Yang Chang
Lan-Yan Yang
Ren-Chin Wu
Chun-Chieh Wang
Hsiu-Jung Tung
Angel Chao
Chyong-Huey Lai

November 2021

Purpose: To investigate the prognostic factors and impact of adjuvant treatment on uterine carcinosa...

Role of surgical staging and adjuvant chemotherapy in the treatment of uterine carcinosarcoma

Cabrera, O.
Cho, C.
Dalmar, Ahmed
Mahdavi, Ali

April 2015

Objectives: To determine the clinical behavior and role of chemotherapy and surgical staging in the ...

Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08)

김용배
김준원
차지혜

October 2017

OBJECTIVE: To investigate the role of radiotherapy (RT) in patients who underwent hysterectomy for u...

The role of multimodal adjuvant therapy for FIGO I-II carcinosarcoma of the uterus:a systematic review

van der Horst, R L
van der Hel, O
Lutgens, L
van der Aa, M
Slangen, B
Kruitwagen, R
Lalisang, R I

July 2022

The uterine carcinosarcoma (UCS) is a rare entity with poor prognosis. Treatment of FIGO I-II UCS us...

Adjuvant Vaginal Cuff Brachytherapy and Patterns of Failure for Early Stage Uterine Carcinosarcoma

Zhu, Simeng
Khalil, Remonda M
Burmeister, Charlotte
Elshaikh, Mohamed A

January 2019

Purpose: Uterine carcinosarcoma (UCS)is a rare histologic type, for which the optimal adjuvant manag...

The Impact of Different Adjuvant Management Strategies on Survival Endpoints in Women with Early Stage Uterine Serous Carcinoma

Cook, Andrew E
Khalil, Remonda M
Burmeister, Charlotte
Dimitrova, Irina
Elshaikh, Mohamed A

November 2020

Purpose/Objective(s): To determine the impact of adjuvant chemotherapy, radiation treatment, combine...

Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study

Versluis, Marco A C
Pielsticker, Cindy
van der Aa, Maaike A
de Bruyn, Marco
Hollema, Harry
Nijman, Hans W

January 2018

OBJECTIVE: Uterine carcinosarcoma is a rare, aggressive subtype of endometrial cancer. Treatment con...

Is the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from That of Grade 3 Endometrioid Adenocarcinoma?

Gungorduk, Kemal
Plett, Helmut
Gulseren, Varol
Meydanli, Mutlu
Boyraz, Gokhan
Ozdemir, IsaAykut
Oge, Tufan

January 2021

Aim: The clinicopathologic characteristics, recurrence patterns, and survival of patients with grade...

Carcinosarcomas of the uterus: prognostic factors and impact of adjuvant treatment

Beckmann, K.
Selva-Nayagam, S.
Olver, I.
Miller, C.
Buckley, E.S.
Powell, K.
Buranyi-Trevarton, D.
Gowda, R.
Roder, D.
Oehler, M.K.

January 2021

Background: Uncertainties remain about the most effective treatment for uterine carcinosarcoma (UCS)...

Supplementary Material for: Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study

Nijman, Hans W.
De Bruyn, Marco
Versluis, Marco
Van Der Aa, Maaike A.
Hollema, Harry
Pielsticker, Cindy
Translational Immunology Groningen (TRIGR)
Targeted Gynaecologic Oncology (TARGON)
University Medical Center Groningen

July 2018

Objective: Uterine carcinosarcoma is a rare, aggressive subtype of endometrial cancer. Treatment con...

Adjuvant treatment modalities, prognostic predictors and outcomes of uterine carcinosarcomas

Gungorduk K.
Ozdemir A.
Ertas I.E.
Gokcu M.
Telli E.
Oge T.
Sahbaz A.

January 2015

Purpose The purpose of this study is to evaluate the clinicopathological characteristics, treatment,...

The Role of Adjuvant Chemotherapy in Surgical Stages I-II Serous and Clear Cell Carcinomas and Carcinosarcoma of the Endometrium A Collaborative Study

Vandenput, Ingrid
Trovik, Jone
Vergote, Ignace
Moerman, Philippe
Leunen, Karin
Berteloot, Patrick
Neven, Patrick
Salvesen, Helga
Amant, Frédéric

January 2011

Objective: To assess the impact of adjuvant chemotherapy in early surgically staged type II endometr...

Clinical outcomes of uterine carcinosarcoma results of 94 patients

Gökçe, Zeynep Kestel
Turan, Taner
Karalok, Alper
Tasçı, Tolga
Üreyen, Işın
Özkaya, Enis
Köse, Mehmet Faruk
Tulunay, Gökhan

January 2015

WOS: 000348831000015PubMed ID: 25611900Objective: We aimed to determine the clinicopathologic featur...

A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma

Abstract

Extracted data

A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma

Abstract

Extracted data

Related items

Related items